RJF Stock Recent News
RJF LATEST HEADLINES
This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DIS, LDOS, RJF, COR and DAL are some of the stocks with high ROE to profit on signs of decelerating inflationary pressures.
The revival of the IB business on the back of clarity on the macroeconomic backdrop and solid trading performance will aid the Zacks Investment Bank industry players like Morgan Stanley MS), Goldman (GS), Robinhood (HOOD) and Raymond James (RJF).
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. OUT, COR, RJF and RMD are some stocks that hold promise.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors with an interest in Financial - Investment Bank stocks have likely encountered both Raymond James Financial, Inc. (RJF) and The Charles Schwab Corporation (SCHW). But which of these two companies is the best option for those looking for undervalued stocks?
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, RJF and KBR are some stocks that hold promise.
Raymond James Financial (RJF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RJF is well-poised for growth on solid PCG segment performance and strategic acquisitions. Yet, volatile capital market performance and high costs are woes.